Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
358 INR | -0.08% | -1.19% | -2.07% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 125.81 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.07% | 599M | B | ||
+18.63% | 84.11B | C+ | ||
+2.04% | 27.25B | C+ | ||
-9.66% | 17.31B | B | ||
-2.14% | 16.83B | A- | ||
+3.96% | 15.92B | A- | ||
+7.75% | 13.68B | B- | ||
+72.83% | 13.29B | C- | ||
+72.50% | 12.73B | C+ | ||
+2.69% | 12.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HCG Stock
- Ratings HealthCare Global Enterprises Limited